Marc Roller
Impact in
- Cancer Research top 1%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- HER2/EGFR in Cancer Research
- Inflammatory Biomarkers in Disease Prognosis
Papers in
- Oncology 9
- HER2/EGFR in Cancer Research 6
- Cancer-related Molecular Pathways 1
-
- Breast Cancer Treatment Studies 5
- Cancer Genomics and Diagnostics 1
- Co-authors
- Sibylle Loibl (9 shared papers)Gϋnter von Minckwitz (4 shared papers)Martina Komor (3 shared papers)Iris Schrader (2 shared papers)Silvia Darb‐Esfahani (4 shared papers)Carsten Denkert (4 shared papers)Berit Maria Müller (4 shared papers)Christine Solbach (8 shared papers)
- Journals
- Breast Cancer Research and Treatment (3 papers)International Journal of Cancer (2 papers)Biochemical Pharmacology (1 paper)BMC Cancer (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Marc Roller
16 papers receiving 2.7k citations
Marc Roller's Hit Papers
Peers
Comparison fields: 5 of 70
- Cancer Research 1.4k
- Oncology 1.1k
- Immunology 190
- Otorhinolaryngology 36
- Pulmonary and Respiratory Medicine 122
Countries citing papers authored by Marc Roller
This map shows the geographic impact of Marc Roller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Roller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Roller more than expected).
Fields of papers citing papers by Marc Roller
This network shows the impact of papers produced by Marc Roller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Roller. The network helps show where Marc Roller may publish in the future.
Co-authors
The 25 scholars most cited alongside Marc Roller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer Hit paper breakdown → | 2009 | 1479 |
| 2 | 2010 | 430 | |
| 3 | 2004 | 189 | |
| 4 | 2011 | 180 | |
| 5 | 2013 | 114 | |
| 6 | 2009 | 95 | |
| 7 | 2004 | 84 | |
| 8 | 2010 | 51 | |
| 9 | 2010 | 41 | |
| 10 | Pituitary tumor-transforming gene (PTTG): a novel target for anti-tumor therapy. | 2005 | 28 |
| 11 | 2002 | 25 | |
| 12 | 2006 | 19 | |
| 13 | 2002 | 12 | |
| 14 | 2002 | 4 | |
| 15 | Cancer of the uterine cervix is susceptible to anti-EGF-R antibody EMD 55,900 therapy. | 2006 | 4 |
| 16 | 2003 | 3 |
About Marc Roller
Marc Roller is a scholar working on Oncology, Cancer Research, Otorhinolaryngology, Pathology and Forensic Medicine and Physiology, having authored 16 papers that have together received 2.8k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (6 papers), Breast Cancer Treatment Studies (5 papers), Mitochondrial Function and Pathology (1 paper), Head and Neck Cancer Studies (1 paper), Cancer Genomics and Diagnostics (1 paper), Cell death mechanisms and regulation (1 paper), Nitric Oxide and Endothelin Effects (1 paper) and Cancer-related Molecular Pathways (1 paper). The work is most often cited by research in Cancer Research (1.4k citations), Oncology (1.1k citations), Immunology (190 citations), Otorhinolaryngology (36 citations) and Pulmonary and Respiratory Medicine (122 citations). Marc Roller has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Sibylle Loibl, Gϋnter von Minckwitz, Martina Komor, Iris Schrader, Silvia Darb‐Esfahani, Carsten Denkert, Berit Maria Müller, Christine Solbach, Aurelia Noske and Manfred Dietel. Their work appears in journals such as Breast Cancer Research and Treatment, International Journal of Cancer, Biochemical Pharmacology, BMC Cancer and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.